Schizophrenia Clinical Trials Database - Free Access to 2,119 Studies
Access comprehensive clinical trial information for Schizophrenia through Pure Global AI's free database. This collection includes 2,119 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 248 trials are actively recruiting participants.
Research for Schizophrenia is being conducted in United States of America, China, Iran and 7+ other countries. Leading sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and Otsuka Pharmaceutical Development & Commercialization, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Effect of Topiramate in treatment of chronic schizophrenia
Developing social skills, communication skills and self confidence through dance, drama and yoga in patients with long term mental illness at NIMH, Angoda
Effectiveness of metformin in reducing weight gain caused by antipsychotics
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
A long-term clinical study using Evenamide (orally taken new drug without masking its strength) to determine its safety, tolerability and efficacy in patients with treatment resistant schizophrenia, not befitting adequately from their current antipsychotic medication
Correlates of Fatigue in People With Schizophrenia
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
The Phase I Study of HS-10509 in Chinese Adult Subjects
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Energetics and Glutamate in Schizophrenia
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
The Hi-tACS on Cognitive Function in Patients With Schizophrenia: a Pilot Study
A Study of ANAVEX3-71 in Adults With Schizophrenia
TMS for Inhibition Enhancement in Schizophrenia
Intermittent Theta Burst Stimulation of the Precuneus
Pure Global AI provides free access to 2,119 clinical trials studying Schizophrenia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Otsuka Pharmaceutical Development & Commercialization, Inc., AstraZeneca, among others.